Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,419,902
+$13,415,204 QoQ
Shares Held
761,153
+150.2% QoQ
Ownership
0.892%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#28
of 193 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nextech Invest, Ltd. holds $2,099,516,941 across 15 Biotechnology names. GLUE ranks #9 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
7,601,087 | $1,423,531,573 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
4,663,176 | $127,631,127 | |
| 3 | RLAY |
Relay Therapeutics, Inc.
|
6,776,506 | $126,788,427 | |
| 4 | TYRA |
Tyra Biosciences, Inc.
|
3,553,585 | $113,501,504 | |
| 5 | ALMS |
Alumis Inc.
|
3,540,998 | $99,643,683 | |
| 6 | ORIC |
Oric Pharmaceuticals, Inc.
|
7,162,637 | $77,571,358 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
278,896 | $31,981,004 | |
| 8 | ZYME |
Zymeworks Inc.
|
1,113,946 | $29,118,548 |
All Filings in GLUE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,419,902 | 761,153 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,004,698 | 304,237 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,378,436 | 279,237 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||